<h1>Pharmaceutical company acquires majority stake for Rs 19,500 crore in India's second-largest pharma deal</h1> A pharmaceutical company announced acquisition of majority stake in another pharmaceutical firm for approximately Rs 19,500 crore, making it India's second most-valued pharma company. The acquiring company will purchase 46.39% stake from promoters for Rs 11,917 crore and additional 2.80% from employees for Rs 719 crore at Rs 1,600 per share. An open offer for 26% from public shareholders will follow at Rs 1,639.18 per share totaling Rs 6,842.8 crore. The deal represents the second largest pharmaceutical sector transaction ever, with total equity valuation of Rs 25,689 crore, followed by merger of both entities.